Project Details
Description
APPLAUD: A double-blinded, randomized, placebo-controlled, Phase 2 study of the efficacy and safety of LAU-7B in the treatment of cystic fibrosis through correction of the AA/DHA imbalance
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/18 → 10/31/21 |
Funding
- LAURENT PHARMACEUTICALS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.